Obesity
Not yet recruitingKAI-9531 in Adults With Obesity or Overweight and Diabetes
KAI-9531 in Adults With Obesity or Overweight and Diabetes
Bulgaria- Participants:18–64 years · 65+ years
- Substances:HRS 9531
- Sponsor:Kailera Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Slovakia246 clinical trials in Nove Mesto Nad Vahom, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)KAI-9531 in Adults With Obesity or Overweight and Diabetes
BulgariaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
SlovakiaA study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis
CzechiaStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
SlovakiaStudy on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis
CzechiaStudy on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis
SlovakiaPhase 3 Randomized Study of RAP-219 to Reduce Seizure Frequency in Adults with Focal Epilepsy
SlovakiaRandomized phase III study of AAA817 plus an androgen receptor pathway inhibitor in adult men with PSMA‑positive metastatic castration‑resistant prostate cancer
SlovakiaLong‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis
SlovakiaEfficacy and Safety of Letrozole SIE Compared with Oral Letrozole, Both with Ribociclib, in Postmenopausal Women with HR‑Positive, HER2‑Negative Metastatic Breast Cancer
SlovakiaA Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease
SlovakiaEvaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in Stara Tura is focused on cardiovascular diseases, with studies involving adults who have atherosclerotic cardiovascular disease and chronic kidney disease. The research is aimed at better understanding how new treatments may lower the risk of serious heart-related events.
These trials are designed to assess whether new therapies can improve prevention of major cardiovascular complications and support better long-term outcomes.
The local research portfolio also addresses overlapping cardiovascular and kidney-related risk, reflecting the close connection between blood vessel disease, blood pressure control, and renal health. This work helps evaluate whether emerging treatments can reduce events such as heart attack, stroke, or heart failure.
In this setting, researchers are focusing on whether new therapies can offer stronger protection than standard care for patients most vulnerable to major cardiovascular events.
Tell us about your condition – we search every trial in Europe and connect you with the right site.